Literature DB >> 8606041

A case of autoimmune hemolytic anemia induced by IFN-beta therapy for type-C chronic hepatitis.

Y Kazuta1, N Watanabe, K Sagawa, H Kobayashi, T Kojima, H Funabashi, T Moritoh, R Kasukawa.   

Abstract

A 51-year old woman who had type-C chronic hepatitis developed autoimmune hemolytic anemia after 4 weeks treatment with a total 48 million interferon-beta, 6 million 8 times. Indirect Coomb's test turned from negative to positive through IFN therapy and a complication of asymptomatic primary biliary cirrhosis was confirmed by histologic findings of the biopsied liver which was performed during IFN therapy and a presence of anti-mitochondrial antibody. After stopping IFN therapy and adding prednisolone anemia improved in getting negative indirect Coombs test but remaining positive direct Coombs test.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8606041

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  3 in total

1.  Haematological effects of interferon-beta-1a (Rebif) therapy in multiple sclerosis.

Authors:  Peter Rieckmann; Paul O'Connor; Gordon S Francis; Graham Wetherill; Enrica Alteri
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Hepatocellular carcinoma with chronic B-type hepatitis complicated by autoimmune hemolytic anemia: a case report.

Authors:  Toshie Okada; Keiichi Kubota; Junji Kita; Masato Kato; Tokihiko Sawada
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

3.  Interferon-Beta-1b Induced Autoimmune Hemolytic Anemia in a Patient with MS: A Case Report.

Authors:  M Saeedi; M Forughipour; P Sasannezhad; A Shoeibi
Journal:  Iran Red Crescent Med J       Date:  2011-03-01       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.